Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis
Public ClinicalTrials.gov record NCT04773587. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, 4-Week, Parallel Group, Double Blind, Vehicle-Controlled Study of the Safety and Efficacy of ARQ-151 Cream 0.15% Administered QD in Subjects With Atopic Dermatitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a parallel group, double blind, vehicle-controlled study to assess the safety and efficacy of roflumilast (ARQ-151) cream vs vehicle applied once daily (qd) for 4 weeks by participants with atopic dermatitis (eczema).
Study identification
- NCT ID
- NCT04773587
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 654 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 6 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 26, 2021
- Primary completion
- Aug 29, 2022
- Completion
- Aug 29, 2022
- Last update posted
- Oct 8, 2024
2021 – 2022
United States locations
- U.S. sites
- 42
- U.S. states
- 21
- U.S. cities
- 40
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arcutis Clinical Site 57 | Montgomery | Alabama | 36117 | — |
| Arcutis Clinical Site 34 | Scottsdale | Arizona | 85255 | — |
| Arcutis Clinical Site 58 | Little Rock | Arkansas | 72212 | — |
| Arcutis Clinical Site 40 | Beverly Hills | California | 90212 | — |
| Arcutis Clinical Site 06 | Encinitas | California | 92024 | — |
| Arcutis Clinical Site 52 | Los Angeles | California | 90056 | — |
| Arcutis Clinical Site 05 | San Diego | California | 92123 | — |
| Arcutis Clinical Site 08 | San Francisco | California | 94132 | — |
| Arcutis Clinical Site 62 | Thousand Oaks | California | 91320 | — |
| Arcutis Clinical Site 30 | Coral Gables | Florida | 33134 | — |
| Arcutis Clinical Site 04 | Jacksonville | Florida | 32256 | — |
| Arcutis Clinical Site 15 | Largo | Florida | 33770 | — |
| Arcutis Clinical Site 39 | Miami Lakes | Florida | 33014 | — |
| Arcutis Clinical Site 38 | North Miami Beach | Florida | 33162 | — |
| Arcutis Clinical Site 01 | Tampa | Florida | 33613 | — |
| Arcutis Clinical Site 61 | Wellington | Florida | 33449 | — |
| Arcutis Clinical Site 26 | Sandy Springs | Georgia | 30328 | — |
| Arcutis Clinical Site 13 | Rolling Meadows | Illinois | 33770 | — |
| Arcutis Clinical Site 48 | Clarksville | Indiana | 47129 | — |
| Arcutis Clinical Site 02 | Indianapolis | Indiana | 46250 | — |
| Arcutis Clinical Site 03 | Louisville | Kentucky | 40217 | — |
| Arcutis Clinical Site 36 | Rockville | Maryland | 20850 | — |
| Arcutis Clinical Site 55 | Auburn Hills | Michigan | 48326 | — |
| Arcutis Clinical Site 54 | Bay City | Michigan | 48706 | — |
| Arcutis Clinical Site 46 | Clarkston | Michigan | 48346 | — |
| Arcutis Clinical Site 37 | Detroit | Michigan | 48202 | — |
| Arcutis Clinical Site 10 | New Brighton | Minnesota | 55112 | — |
| Arcutis Clinical Site 33 | Reno | Nevada | 89509 | — |
| Arcutis Clinical Site 42 | East Windsor | New Jersey | 08520 | — |
| Arcutis Clinical Site 17 | Gresham | Oregon | 97030 | — |
| Arcutis Clinical Site 16 | Portland | Oregon | 97223 | — |
| Arcutis Clinical Site 14 | Portland | Oregon | 97239 | — |
| Arcutis Clinical Site 35 | Newtown Square | Pennsylvania | 19073 | — |
| Arcutis Clinical Site 101 | Johnston | Rhode Island | 02919 | — |
| Arcutis Clinical Site 31 | Murfreesboro | Tennessee | 37130 | — |
| Arcutis Clinical Site 19 | Arlington | Texas | 76011 | — |
| Arcutis Clinical Site 43 | Bellaire | Texas | 77401 | — |
| Arcutis Clinical Site 27 | Houston | Texas | 77030 | — |
| Arcutis Clinical Site 20 | Houston | Texas | 77056 | — |
| Arcutis Clinical Site 28 | San Antonio | Texas | 78218 | — |
| Arcutis Clinical Site 21 | South Jordan | Utah | 84095 | — |
| Arcutis Clinical Site 12 | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04773587, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 8, 2024 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04773587 live on ClinicalTrials.gov.